To restart com­mon can­cer drug pro­duc­tion short­ly, FDA work­ing close­ly with Ac­cord

The short­age of the com­mon and cheap can­cer drugs cis­platin and car­bo­platin has been an on­go­ing, na­tion­al headache. But the FDA be­lieves that the sit­u­a­tion may im­prove soon.

In an email to End­points News, a spokesper­son for the FDA said that the agency “un­der­stands that man­u­fac­tur­ers ex­pect avail­abil­i­ty” of cis­platin and car­bo­platin and that it is ex­pect­ing more sup­plies to in­crease “in the near fu­ture.”

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER